Background: Eczema (atopic dermatitis) is associated with an increased risk of having IgE antibodies. IgE sensitization can occur through an impaired skin barrier. Filaggrin gene (FLG) mutation is associated with eczema and possibly also with IgE sensitization. Objective: We sought to explore the longitudinal relation between preschool eczema (PSE), FLG mutation, or both and IgE sensitization in childhood. Methods: A total of 3201 children from the BAMSE (Children Allergy Milieu Stockholm Epidemiology) birth cohort recruited from the general population were included. Regular parental questionnaires identified children with eczema. Blood samples were collected at 4, 8, and 16 years of age for analysis of specific IgE. FLG mutation analysis was performed on 1890 of the children. Results: PSE was associated with IgE sensitization to both food allergens and aeroallergens up to age 16 years (overall adjusted odds ratio, 2.30; 95% CI, 2.00-2.66). This association was even stronger among children with persistent PSE. FLG mutation was associated with IgE sensitization to peanut at age 4 years (adjusted odds ratio, 1.88; 95% CI, 1.03-3.44) but not to other allergens up to age 16 years. FLG mutation and PSE were not effect modifiers for the association between IgE sensitization and PSE or FLG mutation, respectively. Sensitized children with PSE were characterized by means of polysensitization, but no other specific IgE sensitization patterns were found. Conclusions: PSE is associated with IgE sensitization to both food allergens and aeroallergens up to 16 years of age. FLG mutation is associated with IgE sensitization to peanut but not to other allergens. Sensitized children with preceding PSE are more often polysensitized. (J Allergy Clin Immunol 2017;140:1572-9.) Key words: Allergens, atopic dermatitis, birth cohort, filaggrin, food allergy, IgE, peanut, population, sensitization, skin barrier Eczema (atopic dermatitis) 1 is an inflammatory skin disorder with onset occurring commonly during the first 2 years of life. Approximately 15% to 30% of children and 2% to 10% of adults in industrialized countries are affected.
Eczema (atopic dermatitis) 1 is an inflammatory skin disorder with onset occurring commonly during the first 2 years of life. Approximately 15% to 30% of children and 2% to 10% of adults in industrialized countries are affected. 2 Eczema is associated with IgE-mediated food allergy, 3 and one third of children with eczema will later have asthma, rhinitis, or both, the so-called atopic march. 4 In 2003, Lack et al 5 demonstrated that the use of skin preparations containing peanut oil was associated with peanut allergy in children. They concluded that IgE sensitization to peanut protein can occur through application of peanut oil to inflamed skin. Defective skin barrier function in patients with eczema allows penetration of allergens, irritants, and bacteria. 6 Thus sensitization to allergens can occur through the defective skin barrier and has been suggested to initiate the atopic march. 7 Brough et al 8 demonstrated that peanut antigens in dust were associated with increased risk of IgE sensitization to peanut and peanut allergy in atopic children. The risk was higher in children with a history of eczema and severe eczema. 8 Loss-of-function mutation in the filaggrin gene (FLG) increases the risk of eczema 9 and also of IgE sensitization, according to a systematic review and meta-analysis. 10 However, recent studies evaluating the association between FLG mutation and IgE sensitization and including eczema as a covariate present conflicting results. [11] [12] [13] [14] [15] FLG encodes an epidermal protein that plays a key role for skin barrier function. 16 FLG mutations in the absence of eczema have been shown to be associated with peanut allergy. 17 In addition, early-life exposure to environmental peanut is reported to be related to increased risk of peanut allergy in children who carry an FLG mutation. 18 These findings support the idea of IgE sensitization through an impaired skin barrier. However, children without visible skin lesions and without any FLG mutation also have IgE sensitization, and a significant proportion of children with eczema never become IgE sensitized. 6 It is well known that children with eczema have increased prevalence of IgE antibodies to common allergens compared with children without eczema. 19, 20 However, potential differences in patterns of IgE sensitization between sensitized children with and without preschool eczema (PSE), FLG mutation, or both have not been explored.
We hypothesized that PSE, FLG mutation, or both are associated with IgE sensitization in childhood, possibly through skin barrier dysfunction, and performed a secondary analysis of the BAMSE database. In addition, we explored whether sensitized children with PSE, FLG mutation, or both present different patterns of IgE sensitization than sensitized children without PSE or FLG mutation.
METHODS

Study design and setting
The BAMSE (Children Allergy Milieu Stockholm Epidemiology) project, which has been described in detail elsewhere, 21 is a population-based cohort including 4089 children followed from birth to age 16 years. Detailed data on residential characteristics, environmental factors, and parental allergy were obtained when the children were around 2 months old from a baseline parental questionnaire. When the children were 1, 2, and 4 years of age, parents completed questionnaires on manifestations of eczema, asthma, and rhinitis during the preceding 12 months, as well as on a doctor's diagnosis of disease since last follow-up. At the 16-year follow-up, 3181 (78%) subjects still remained in the cohort. The design of the current study was done post hoc to data collection, but the hypotheses being tested were derived before interrogation of the data set.
Blood analyses
Blood was collected for analysis of serum IgE antibodies to a mix of common airborne and food allergens at 4, 8, and 16 years of age. Airborne allergens were analyzed with Phadiatop (cat, dog, horse, birch, timothy, mugwort, house dust mite [HDM; Dermatophagoides pteronyssinus at 4 and 8 years of age or Dermatophagoides pteronyssinus, Dermatophagoides farinae, or both at 16 years of age], and mold [Cladosporium herbarum]), and food allergens were analyzed with fx5 (cow's milk, hen's egg, cod, soy, peanut, and wheat) by using the ImmunoCAP System (Thermo Fisher Scientific, Uppsala, Sweden). Results were expressed as positive (> _0.35 kU A /L) or negative (<0.35 kU A /L). To be classified as sensitized at each respective age, a child was required to have positive results for Phadiatop, fx5, or both. Sera with Phadiatop or fx5 results of 0.35 kU A /L or greater were subsequently analyzed for IgE antibodies to the airborne and food allergens listed above. Sensitization to a specific allergen at each respective age was defined as an IgE level of 0.35 kU A /L or greater to that allergen. All samples were analyzed in accordance with the instructions of the manufacturer at the Department of Clinical Immunology, Karolinska University Hospital Solna, Stockholm, Sweden.
In addition, genotyping for the FLG mutations common in Scandinavia was done among children who provided blood at 8 years of age. 22 Genotyping was performed with TaqMan allelic discrimination for R501X and R2447X on the ABI Prism 7500 detection system in accordance with the manufacturer's protocol (Applied Biosystems, Foster City, Calif) and matrix-assisted laser desorption/ionization time-of-flight spectrometry (Sequenom GmbH, Hamburg, Germany) for 2282del4. Primer sequences, amplification conditions, and allele sizes are available on request. Children with a mutation in any of the positions 2282del4, R501X, or R2447X were classified as having an FLG mutation.
Study population
Children with data on PSE (n 5 3700) who provided blood at least once (n 5 3316) constituted the study population (n 5 3201 [78.3%] of the original cohort). FLG mutation analysis was available for a subset of 59.0% of the children in the study population. When analyzing the pattern of IgE sensitization, children with complete data on specific IgE levels and positive IgE results for aeroallergens, food allergens, or both were included (Fig 1) .
Definitions
PSE was defined as parental report of dry skin and itchy rash for 2 weeks or more with specific rash locations (face or arm/leg extension surfaces or arm/leg flexures or wrist/ankles or neck) in the last 12 months and/or a doctor's diagnosis of eczema since the last follow-up at 1 or more of the follow-ups at age 1, 2, and 4 years. 23 Persistent PSE was defined as eczema at age 1, 2, and 4 years. Severe PSE was defined as eczema in combination with sleep disturbance caused by itch at age 1, 2, and/or 4 years.
Monosensitization was defined as an IgE level of 0.35 kU A /L or greater to a single allergen or a positive Phadiatop and/or fx5 result without reaching 0.35 kU A /L or greater to any of the allergens included in the mixes.
Oligosensitization was defined as an IgE level of 0.35 kU A /L or greater to 2 or 3 allergens.
Polysensitization was defined as an IgE level of 0.35 kU A /L or greater to 4 or more allergens.
Statistics
Background characteristics were expressed as the percentage of the total number of subjects observed and 95% CIs adjusted for finite population sampling. 24 To assess the association between IgE sensitization (any allergens, food allergens, and aeroallergens) at 4, 8, and 16 years of age and PSE, FLG mutation, or both, we used a logistic regression model with generalized estimating equations (GEE) and an unstructured correlation matrix to account for the correlation between repeated outcomes. Unstructured correlation was used because of the longitudinal design and the unequal spacing to the follow-up point in time. GEE analyses were performed on both prevalent and incident cases at 8 and 16 years of age. Potential effect modifiers for the association between PSE and FLG mutation, respectively, and IgE sensitization were investigated by using logistic regression for each covariate separately (sex, heredity, breast-feeding, parental smoking during infancy, mother's age, socioeconomic status, FLG mutation, and, in FLG mutation analysis, PSE).
To investigate whether associations between PSE and sensitization outcomes were different at different ages, we added an interaction term to the model. A separate model was used for each outcome: any sensitization, sensitized to food allergens, and sensitized to aeroallergens. The same procedure was repeated for the effect of FLG mutation. We decided a priori to include sex and heredity in the models, and other potential confounders (listed above) were included if the univariate analysis changed the odds ratio (OR) by greater than 10%. Logistic regression was also used when calculating ORs for the association between PSE and monosensitization, oligosensitization, and polysensitization (children without IgE sensitization were the reference category). In the investigatordriven pattern analysis, x 2 tests were used for dichotomous variables. P values of less than .05 were considered statistically significant. The analyses above were not adjusted for multiple hypothesis testing. For the data-driven pattern analysis (cluster analysis), we included all allergens as dichotomous variables (positive or negative). Because of our large data set, we used the k-means method with Euclidean distance between the observations because this produced the most stable clusters compared with other methods tested (Jaccard and matching). This analysis was performed separately at age 4, 8, and 16 years.
We tested 2-, 3-, 4-, and 5-cluster models and selected the clusters that maximized the Calinski-Harabasz pseudo-F. 25 Cluster analysis was initially performed separately for sensitized children with and without PSE at each age and thereafter including all sensitized children at each age.
All statistical calculations were performed with Stata Statistical Software (release 12.1; StataCorp, College Station, Tex).
Ethics
This study was approved by the Regional Ethical Review Board at Karolinska Institutet, Stockholm. Informed consent was provided by teenagers and guardians.
RESULTS
Participants and descriptive data
There were no differences in background characteristics between the study participants (n 5 3201) and the original cohort, with the exception of socioeconomic status and heredity (see Table E1 in this article's Online Repository at www. jacionline.org). In the study population 1107 (34.6%) had PSE; of these, 381 (34.4%) had severe PSE, whereas 214 (19.3%) had persistent PSE. Among the 1890 children analyzed for FLG mutation, 137 (7.3%) had any FLG mutation; of these, 48.9% (n 5 67) had PSE. FLG mutation was more common among children with PSE compared with children without PSE (10.1% vs 5.7%, P < .001).
Logistic regression analysis: IgE sensitization in relation to PSE
A history of PSE was positively associated with any IgE sensitization (overall adjusted odds ratio [aOR], 2.39; 95% CI, 2.00-2.63) from 4 to 16 years of age. This positive association was found for both food allergens (aOR, 2.05; 95% CI, 1.74-2.42) and aeroallergens (aOR, 2.51; 95% CI, 2.18-2.92) up to age 16 years when analyzed separately. The highest OR associated with PSE was for aeroallergens at age 4 years (Fig 2, A) . The point estimates were higher for children with severe PSE and significantly higher for children with persistent PSE for both food allergens and aeroallergens, with the strongest association for sensitization to airborne allergens at age 4 years (aOR, 9.28; 95% CI, 6.64-12.97; Table I ). We also analyzed the association between PSE and IgE sensitization to separate allergens at 4, 8, and 16 years of age and found that PSE was significantly associated with IgE sensitization to almost all of the 14 included allergens (see Table E2 in this article's Online Repository at www.jacionline. org). PSE was also associated with incident IgE sensitization at age 8 years (aOR, 1.44; 95% CI, 1.08-1.91) and age 16 years (aOR, 1.48; 95% CI, 1.08-2.03). FLG mutation was not a significant modifier to the effect of PSE on IgE sensitization, and adjustment for FLG mutation did not change the ORs (data not shown).
Both preschool asthma and preschool rhinitis were significant effect modifiers of the effect of PSE on IgE sensitization. Stratification by preschool asthma and rhinitis revealed that the OR for any IgE sensitization or sensitization to food allergens and aeroallergens was more pronounced among children with preschool asthma or rhinitis (data not shown). The overall OR for the association between PSE and any sensitization up to age 16 years among children without asthma or rhinitis before age 4 years was still significant (aOR, 1.85; 95% CI, 1.57-2.19).
Logistic regression analysis: IgE sensitization in relation to FLG mutation FLG mutation was not associated with IgE sensitization at 4, 8, or 16 years of age (Fig 2, B) . However, when we evaluated all allergens separately, FLG mutation was associated with IgE sensitization to peanut at age 4 years (aOR, 1.88; 95% CI, 1.03-3.44) and to HDM at age 16 years (aOR, 0.47; 95% CI, 0.23-0.96) but not to other allergens (see Table E3 in this article's Online Repository at www.jacionline.org). PSE did not modify the effect of FLG mutation on IgE sensitization, and stratification by PSE and heredity resulted in minor differences.
IgE sensitization in the whole study population
Proportions of any IgE sensitization increased over time from 24.3% (622/2560) at age 4 years to 35.0% (832/2378) at age 8 years and 46.1% (1135/2464) at age 16 years. Children with PSE had an increased risk for monosensitization, oligosensitization, and polysensitization at all ages compared with children without PSE. The risk was most pronounced at age 4 years (monosensitization: aOR, 1.79; 95% CI, 1.40-2.30; oligosensitization: aOR, 2.73; 95% CI, 2.01-3.72; and polysensitization: aOR, 7.91; 95% CI, 5.18-12.08).
Patterns of IgE sensitization among sensitized children
In the subpopulations (children with any IgE sensitization at 4, 8, or 16 years of age), monosensitization was most common among children without PSE, whereas polysensitization was most common among children with PSE (Fig 3) . Among sensitized children, children with PSE had a higher prevalence of IgE sensitization to most allergens than children without PSE. However, sensitization to HDM, milk, and fish at 4, 8, and 16 years of age did not differ between children with and without PSE (Fig 4) .
There were no differences in monosensitization, oligosensitization, and polysensitization when comparing sensitized children with and without FLG mutation (see Table E4 in this article's Online Repository at www.jacionline.org). However, when we explored the prevalence of single allergens, we found that IgE antibodies to peanut were significantly more common among children with FLG mutation at 4 years (43.3% vs 22.3%, P 5 .010) and 8 years (36.0% vs 21.8%, P 5 .022) but not at 16 years (16.4% vs 17.1%, P 5 .89) of age. Children with FLG mutation in combination with PSE had the highest prevalence of IgE sensitization to peanut at 4 and 8 years of age (Table II) . There were no other significant differences in IgE sensitization to single allergens when comparing those with and without FLG mutation (see Table E4 ). Children with data on PSE who provided blood at least once were included in the analysis (n 5 3201). We used a logistic regression model with GEE adjusted for sex and heredity. Effect modification was tested for sex, heredity, breast-feeding, parental smoking during infancy, mother's age, socioeconomic status, and FLG mutation. B, Association between FLG mutation and IgE sensitization at 4, 8, and 16 years of age. Children from the BAMSE cohort with data on FLG mutation and PSE were included in the analysis (n 5 1890). We used a logistic regression model with GEE adjusted for PSE, sex, and heredity. Effect modification was tested for sex, heredity, breast-feeding, parental smoking during infancy, mother's age, socioeconomic status, and PSE.
Cluster analysis of IgE sensitization
Finally, we used a data-driven approach and performed a cluster analysis on all 14 allergens stratified by PSE to evaluate whether there were any specific patterns of sensitization among children with and without a history of PSE. We found that a 2-cluster model was the most stable model at all ages for sensitized children with PSE. For sensitized children without PSE, no stable cluster model was found, and therefore we were unable to compare sensitization patterns between sensitized children with and without a history of PSE. Instead, we performed cluster analysis including all children with any IgE sensitization at the ages of 4, 8, and 16 years. The 2-cluster model was most stable and produced the highest CalinskiHarabasz pseudo-F value at all ages. 25 The first cluster was characterized by monosensitization and oligosensitization, and the second cluster was characterized by polysensitization. PSE was significantly more common in the latter. This difference decreased with age but was still significant at age 16 years (54.6% vs 38.8%, P < .001). The cluster analysis did not provide any additional patterns of IgE sensitization associated with PSE. FLG mutation was equally common in both clusters (4 years: 7.8% vs 8.3%, P 5 .89; 8 years: 6.7% vs 9.6%, P 5 .20; and 16 years: 8.4% vs 6.1%, P 5 .22; see Table E5 in this article's Online Repository at www.jacionline.org).
DISCUSSION
Main findings
In this population-based birth cohort, we explored IgE sensitization in relation to both PSE and FLG mutation and found that PSE was positively associated with IgE sensitization to both food allergens and aeroallergens at age 4, 8, and 16 years. This association was even stronger among children with a history of persistent PSE. FLG mutation was positively associated with IgE sensitization to peanut at age 4 years but not with IgE sensitization to other common food allergens or aeroallergens. When exploring patterns of IgE sensitization to 14 single allergens among sensitized children, we found that the group with a history of PSE was characterized by polysensitization and a higher prevalence of IgE antibodies to most food allergens and aeroallergens at 4, 8, and 16 years of age. We also found that sensitized children with FLG mutation had a higher prevalence of IgE sensitization to peanut at 4 and 8 years of age. Other sensitization patterns did not Children with sleep disturbance in combination with eczema at 1, 2, and/or 4 years of age. Children with PSE without sleep disturbance and missing data at 1 or 2 ages were excluded. Children without PSE (n 5 2094) were the reference group. àChildren with eczema at 1, 2, and 4 years of age. Children without PSE (n 5 2094) were the reference group.
§Children without PSE and FLG mutation (n 5 1157) were the reference group. kLogistic regression model using GEE adjusted for sex and heredity. Effect modification was tested for sex, heredity, breast-feeding, parental smoking during infancy, mother's age, socioeconomic status, and FLG mutation. differ between sensitized children with and without FLG mutation.
Strengths and limitations
This study has several strengths, especially the large number of participants recruited from the general population with follow-up from birth to age 16 years. The eczema criteria in the questionnaire have been validated with a sensitivity and specificity of 92% and 100%, respectively. 26 Thus there is a decreased risk of misclassification of our collected PSE data, as well as for several other prospectively collected covariates. This allows for adjustment for potential confounders, including parental allergy. In , and 16 (C) years of age by PSE. Bars represent the proportions of children in each group with specific IgE > _0.35 kU A /L for the respective allergen. Children in the BAMSE cohort with any IgE sensitization and complete data on specific IgE measurement at respective ages were included. *Significant differences.
J ALLERGY CLIN IMMUNOL VOLUME 140, NUMBER 6 addition, IgE sensitization was measured at 3 time points, including measurement of a large number of food allergens and airborne allergens. Another advantage was that we used both an investigator-and a data-driven (cluster analysis) approach when analyzing patterns of sensitization. One limitation is that we did not have data on IgE sensitization before age 4 years. Thus we could not explore whether IgE sensitization preceded symptoms of eczema or vice versa. Another limitation is that FLG mutation data were not available in all participants, but on the other hand, few longitudinal studies have analyzed FLG mutation in nearly 1900 patients.
Results in the context of the existing literature
We found a positive association between PSE and any IgE sensitization up to age 16 years. In the Isle of Wight cohort investigators analyzed IgE sensitization to food allergens and aeroallergens in relation to eczema up to age 4 years and found an association comparable with our result at age 4 years. 20 In line with previous research, we found a clear association between IgE sensitization to food allergens and PSE. 3, 27 Flohr et al 13 showed that the association between eczema and food sensitization was stronger with disease severity. We made a similar finding, and in addition, we found that children with persistent PSE had even higher point estimates for food sensitization. Few studies have investigated the association between PSE and sensitization to aeroallergens later in life. We were surprised to find even stronger associations between PSE and airborne allergens than between PSE and food allergens. Notably, these associations were strongest at age 4 years, even though sensitization to airborne allergens is more prevalent later in life. We hypothesized that FLG mutation is associated with IgE sensitization, and in this large study we found that FLG mutation, irrespective of eczema, was associated with IgE sensitization to peanut at 4 years. These findings are in line with previous studies having shown that FLG mutation is associated with both peanut sensitization and peanut allergy. 17, 18 However, we did not find any other significant associations between FLG mutation and IgE sensitization to other common food allergens. Several studies have investigated the association between FLG mutations and IgE sensitization to foods with conflicting results. In contrast to our findings, Tan et al 11 found that FLG mutation was associated with IgE sensitization to food also after adjustment for eczema. Other studies have also found an association between FLG mutation and IgE sensitization to foods, but this association was not evident in the absence of prior eczema. 12, 14 Later studies have not found an association between IgE sensitization to food allergens and FLG mutation. 13, 15 We also found that FLG mutation was associated with IgE sensitization to HDM at age 16 years (see Table E4 ). Very few studies have analyzed the association between FLG mutation and IgE sensitization to aeroallergens, and there is thus far no support of our findings in the literature. 12, 15 Thus it is possible that the association between FLG mutation and HDM occurred by chance because of multiple testing. We cannot rule out that this was also the case for the association between FLG mutation and peanut sensitization, but in view of previous publications, we consider this less likely. 18 Environmental peanut exposure in dust has been shown to be related to peanut sensitization, possibly through the skin. 8, 18 However, other food allergens and aeroallergens, including HDM, are also found in house dust. 28, 29 Additional studies are needed to understand why FLG mutation is associated with IgE sensitization to certain allergens but not others.
For the first time, we have compared patterns of IgE sensitization among sensitized children in relation to PSE and FLG mutations. The finding that sensitized children with a history of PSE had a higher degree of polysensitization at all ages compared with sensitized children with no history of PSE is new and adds to recent publications concerning IgE polysensitization. [30] [31] [32] Among sensitized children, children with PSE had a greater prevalence of IgE sensitization to most common food and aeroallergens. In contrast, FLG mutation among sensitized children was not associated with polysensitization, and the only pattern that we found among these children was that sensitization to peanut was more common at 4 and 8 years of age.
Our results support the idea that eczema increases the risk of IgE sensitization, possibly through skin barrier dysfunction. We believe that some findings in particular point to a causal relationship between skin barrier dysfunction and IgE sensitization: (1) that the strongest associations between eczema and IgE sensitization to food and airborne allergens was found at age 4 years, even though sensitization to airborne allergens is more prevalent later in life; (2) that the associations between eczema and IgE sensitization were significantly stronger among children with persistent eczema, representing a group with longer exposure regarding skin barrier dysfunction; and (3) that sensitized children with a history of eczema more often displayed polysensitization compared with sensitized children without a history of PSE.
However, the complex etiology of atopic diseases makes causal inference difficult, and our findings might be explained by other factors. By including only sensitized children when analyzing patterns of sensitization in relation to PSE or FLG mutations, we ensured that the comparison was made among subjects with a similar phenotype or genotype disposed to produce specific IgE. The material also enabled us to adjust for parental allergy. However, eczema and skin barrier dysfunction alone cannot explain the development of IgE sensitization, and we have previously shown that almost 50% of children who display any IgE sensitization up to 16 years of age have no history of eczema. 33 Thus an alternative explanation to our findings might be that there are various genetic phenotypes predisposing to eczema and sensitization, regardless of skin barrier dysfunction.
Conclusions
We show that eczema in the first 4 years of life is strongly associated with IgE sensitization both to food allergens and aeroallergens throughout childhood. For children who have had persistent eczema, this association is even stronger. Our study confirms previously described associations between FLG mutation and IgE sensitization to peanut but not to other allergens. This finding implies that FLG mutation without PSE does not seem to play a major role in IgE sensitization. Our results highlight the importance of including data on eczema in the first years of life in future studies aiming to explore FLG mutations in relation to IgE sensitization.
We thank all the children and parents who participated in the BAMSE project.
Key messages
d PSE is positively associated with IgE sensitization to food allergens and aeroallergens up to age 16 years, and this association is even stronger among children with persistent PSE.
d FLG mutation irrespective of eczema is positively associated with IgE sensitization to peanut at age 4 years but not to other food allergens or aeroallergens up to age 16 years. This finding implies that FLG mutation without PSE does not seem to play a major role in IgE sensitization.
d Sensitized children with a history of PSE are more often polysensitized. Children without PSE (n 5 2094) were the reference group. Significant differences are shown in in boldface. *Logistic regression model using GEE adjusted for sex and heredity. Effect modification was tested for sex, heredity, breast-feeding, parental smoking during infancy, mother's age, socioeconomic status, and FLG mutation. Children without FLG mutation (n 5 1753) were the reference group. Significant differences are shown in boldface. *Logistic regression model using GEE adjusted for sex, heredity, and PSE. Effect modification was tested for sex, heredity, breast-feeding, parental smoking during infancy, mother's age, socioeconomic status, and PSE. None of the children with FLG mutation displayed IgE sensitization to mold at 4 and 16 years of age. àNone of the children with FLG mutation displayed IgE sensitization to fish at 8 and 16 years of age. Results of a descriptive analysis in a 2-cluster model among children with any IgE sensitization at each respective age are shown. Significant differences are shown in boldface. *Mother and/or father with doctor's diagnosis of asthma and/or hay fever and/or eczema (contact allergy among parents is excluded) at baseline. Any of the parents smoked at least 1 cigarette per day at birth.
